Global Drug Discovery Informatics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

Description

List of Tables

Global Drug Discovery Informatics Market size is anticipated to grow from USD 3647.43 Million in 2024 to USD 7984.27 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period of 2026 to 2033.

The drug discovery informatics market is experiencing significant growth, driven by the increasing complexity of drug development processes and the need for efficient data management solutions. Drug discovery informatics encompasses a range of tools and technologies that facilitate the analysis, visualization, and management of biological and chemical data throughout the drug development lifecycle. As pharmaceutical companies seek to accelerate their research and development efforts, the demand for informatics solutions that enhance collaboration and data integration is expected to rise, positioning this market for robust expansion.

Moreover, advancements in informatics technologies are propelling innovation within the drug discovery informatics market. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics is transforming the way researchers analyze vast datasets, enabling more efficient identification of potential drug candidates. These technologies facilitate predictive modeling, virtual screening, and data mining, significantly reducing the time and cost associated with drug discovery. As research continues to explore new methodologies and applications in drug discovery informatics, the market is likely to expand further, driven by the promise of enhanced efficiency and innovation in drug development.

Additionally, the growing emphasis on collaboration and data sharing among research institutions and pharmaceutical companies is shaping the drug discovery informatics landscape. As stakeholders recognize the value of collaborative research efforts, the demand for informatics solutions that support data integration and sharing across platforms is likely to increase. This trend is particularly relevant in the context of open science initiatives, where transparency and accessibility of data are essential for advancing drug discovery efforts. As the drug discovery informatics market continues to evolve, the combination of technological advancements, collaborative research models, and a focus on data-driven decision-making will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

Drug Discovery
Drug Development

By Function

Sequencing and Target Data Analysis
Library and Database Preparation
Docking
Molecular Modelling
Others

By End User

Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Other End Users
COMPANIES PROFILED
Certara Inc.
Accenture
Thermo Fisher Scientific Inc.
Jubilant Pharmova
Oracle Corporation
Albany Molecular Research Inc.
The above list can be customized.

Product Code: VMR112115285

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DRUG DISCOVERY INFORMATICS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Function
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Drug Discovery Historic and Forecast Sales By Regions
5.4. Drug Development Historic and Forecast Sales By Regions

6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY FUNCTION

6.1. Overview By Function
6.2. Historical and Forecast Data Analysis By Function
6.3. Sequencing and Target Data Analysis Historic and Forecast Sales By Regions
6.4. Library and Database Preparation Historic and Forecast Sales By Regions
6.5. Docking, Molecular Modelling Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Biotechnology Companies Historic and Forecast Sales By Regions
7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
7.5. Contract Research Organizations Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG DISCOVERY INFORMATICS COMPANIES

9.1. Drug Discovery Informatics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF DRUG DISCOVERY INFORMATICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Certara
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Boehringer Ingelheim International GmbH
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Infosys Ltd.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Charles River Laboratories
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Collaborative Drug Discovery Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Eurofins DiscoverX Products
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Jubliant Biosys
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Selvita
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Novo Informatics Pvt. Ltd.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. ChemAxon Ltd.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Albany Molecular Research Inc.
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Oracle
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Accenture
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. Agilent Technologies Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Illumina Inc
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies